NEW YORK (TheStreet) -- CHANGE IN RATINGS
Aetna (AET) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $83. Company is keeping a tight lid on costs and should realize higher synergies from the CVH deal, Credit Suisse said.
Albermarle (ALB) was upgraded at Bank of America/Merrill Lynch to buy from neutral. Twelve-month price target is $71. See improved growth in catalysts over the coming quarters, BofA/Merrill said.
Avery Dennison (AVY) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $57. Stock is trading at a discount to its peers and management should continue to execute, Robert Baird said.
American Axle & Manufacturing (AXL) was upgraded to buy at TheStreet Ratings.
Buffalo Wild Wings (BWLD) was downgraded at Morgan Stanley to underweight. Valuation call, Morgan Stanley said. Twelve-month price target is $143.
CACI International (CACI) was upgraded at J.P. Morgan to overweight from neutral. Driven by relative value in SMID defense and an eventual shift back to the more typical pensions-adjusted EPS from GAAP as basis for valuing large-cap defense, J.P. Morgan said.Commerce Bancshares (CBSH) was upgraded at Bank of America/Merrill Lynch to neutral. Twelve-month price target is $46. Margin stabilization should support spread revenue growth, BofA/Merrill said.
CVS Caremark (CVS) was initiated with an outperform rating at Leerink Swann. Twelve-month price target is $85. Retail and mail PBM model should drive growth, Leerink Swann said. (CYN) was upgraded at Bank of America/Merrill Lynch to neutral from underperform. Twelve-month price target is $80. Company is leveraged to higher interest rates and can generate high growth, BofA/Merrill said. Dupont (DD) was upgraded at Bank of America/Merrill Lynch to buy from neutral. Twelve-month price target is $70. Company is inexpensive and has leverage to growing demand for specialty chemicals, BofA/Merrill said.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV